Description

According to a report by StrategyHelix, the global 3d bioprinting market is set to increase by US$ 1,538.1 million during 2022-2028, growing at a CAGR of 17.3% during the forecast period.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for 3d bioprinting. The global 3d bioprinting market is segmented on the basis of components, technology, material, application, end user, and region. On the basis of components, the global 3d bioprinting market has been segmented into 3D bioprinters, bioinks. By technology, the global 3d bioprinting market has been segmented into inkjet bioprinting, laser assisted bioprinting, magnetic levitation bioprinting, syringe/extrusion bioprinting, others. Based on material, the global 3d bioprinting market is categorized into extracellular matrices, hydrogels, living cells, others. On the basis of application, the global 3d bioprinting market has been segmented into clinical, research. By end user, the global 3d bioprinting market has been segmented into biopharmaceutical companies, regenerative medicine companies, research organizations & academic institutes, others. Geographically, the global 3d bioprinting market is segmented into Asia Pacific, Europe, North America, Rest of the World (RoW).

The global 3d bioprinting market is highly competitive. The prominent players operating in the global 3d bioprinting market include 3D Systems Corporation (Allevi Inc.), Advanced Solutions Life Sciences LLC (ASLS), Aspect Biosystems Ltd., BICO Group AB (Formerly Cellink AB), Cyfuse Biomedical K.K., EnvisionTEC GmbH (Desktop Metal Inc.), GeSIM GmbH, Inventia Life Science Pty Ltd., Nano3D Biosciences Inc. (n3D), Organovo Holdings Inc., Poietis SAS, regenHU Ltd., Regenovo Biotechnology Co. Ltd., ROKIT Healthcare INC., Stratasys Ltd., Vivax Bio LLC (3D Bioprinting Solutions). Competitive landscape gives a description of the competitive nature of the global 3d bioprinting market and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the 3d bioprinting market to help drive informed decision making for industry executives, policy makers, academic, and analysts.


Report Scope

Components: 3D bioprinters, bioinks
Technology: inkjet bioprinting, laser assisted bioprinting, magnetic levitation bioprinting, syringe/extrusion bioprinting, others
Material: extracellular matrices, hydrogels, living cells, others
Application: clinical, research
End user: biopharmaceutical companies, regenerative medicine companies, research organizations & academic institutes, others
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2018 to 2028
Company mentioned: 3D Systems Corporation (Allevi Inc.), Advanced Solutions Life Sciences LLC (ASLS), Aspect Biosystems Ltd., BICO Group AB (Formerly Cellink AB), Cyfuse Biomedical K.K., EnvisionTEC GmbH (Desktop Metal Inc.), GeSIM GmbH, Inventia Life Science Pty Ltd., Nano3D Biosciences Inc. (n3D), Organovo Holdings Inc., Poietis SAS, regenHU Ltd., Regenovo Biotechnology Co. Ltd., ROKIT Healthcare INC., Stratasys Ltd., Vivax Bio LLC (3D Bioprinting Solutions)


Key Benefits for Stakeholders

– Get a comprehensive picture of the global 3d bioprinting market
– Identify regional strategies and strategic priorities on the basis of local data
– Pinpoint growth sectors and trends for investment


Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. 3d bioprinting market overview
Part 3. Market breakdown by components
– 3D bioprinters
– Bioinks
Part 4. Market breakdown by technology
– Inkjet bioprinting
– Laser assisted bioprinting
– Magnetic levitation bioprinting
– Syringe/extrusion bioprinting
– Others
Part 5. Market breakdown by material
– Extracellular matrices
– Hydrogels
– Living cells
– Others
Part 6. Market breakdown by application
– Clinical
– Research
Part 7. Market breakdown by end user
– Biopharmaceutical companies
– Regenerative medicine companies
– Research organizations & academic institutes
– Others
Part 8. Market breakdown by region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
Part 9. Key companies
– 3D Systems Corporation (Allevi, Inc.)
– Advanced Solutions Life Sciences, LLC (ASLS)
– Aspect Biosystems Ltd.
– BICO Group AB (Formerly Cellink AB)
– Cyfuse Biomedical K.K.
– EnvisionTEC GmbH (Desktop Metal Inc.)
– GeSIM GmbH
– Inventia Life Science Pty Ltd.
– Nano3D Biosciences, Inc. (n3D)
– Organovo Holdings Inc.
– Poietis SAS
– regenHU Ltd.
– Regenovo Biotechnology Co., Ltd.
– ROKIT Healthcare, INC.
– Stratasys Ltd.
– Vivax Bio, LLC (3D Bioprinting Solutions)
About StrategyHelix
Disclaimer


USD 650

Product Type

Industry Statistics

Release Date

October 2022

Region

Global

Pages

15

REQUEST SAMPLE

Global 3D Bioprinting Market 2022

Please fill out our form and we will get back to you.

CUSTOM RESEARCH

Global 3D Bioprinting Market 2022

Please fill out our form and we will get back to you.

login